Archives of Pediatric Infectious Diseases

Published by: Kowsar

Disseminated Bacille Calmette-Guérin Infection in Immunodeficient Infants: Report of Two Cases

Ahmed Ben Hadj Hassine 1 , 2 , * , Manel Marzouk 1 , Hichem Bargui 1 , 2 , Miniar Tfifha 3 , Mohamed Dhaou 1 and Jalel Boukadida 1
Authors Information
1 Laboratory of Microbiology and Immunology, University Hospital Farhat Hached, Sousse, Tunisia
2 Faculty of Pharmacy of Monastir, University of Monastir, Monastir, Tunisia
3 Service of Pediatrics Diseases, University Hospital Sahloul, Sousse, Tunisia
Article information
  • Archives of Pediatric Infectious Diseases: April 2017, 5 (2); e59873
  • Published Online: October 3, 2016
  • Article Type: Case Report
  • Received: March 6, 2016
  • Revised: August 21, 2016
  • Accepted: September 5, 2016
  • DOI: 10.5812/pedinfect.37490

To Cite: Ben Hadj Hassine A, Marzouk M, Bargui H, Tfifha M, Dhaou M, et al. Disseminated Bacille Calmette-Guérin Infection in Immunodeficient Infants: Report of Two Cases, Arch Pediatr Infect Dis. 2017 ; 5(2):e59873. doi: 10.5812/pedinfect.37490.

Copyright © 2016, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Marchant A, Goetghebuer T, Ota MO, Wolfe I, Ceesay SJ, De Groote D, et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol. 1999; 163(4): 2249-55[PubMed]
  • 2. Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet. 2006; 367(9517): 1173–80[DOI]
  • 3. Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A. Immunological conditions of children with BCG disseminated infection. Lancet. 1995; 346(8974): 581[PubMed]
  • 4. Cohn DL. Use of the bacille Calmette-Guerin vaccination for the prevention of tuberculosis: renewed interest in an old vaccine. Am J Med Sci. 1997; 313(6): 372-6[PubMed]
  • 5. Gonzalez B, Moreno S, Burdach R, Valenzuela MT, Henriquez A, Ramos MI, et al. Clinical presentation of Bacillus Calmette-Guerin infections in patients with immunodeficiency syndromes. Pediatr Infect Dis J. 1989; 8(4): 201-6[PubMed]
  • 6. Casanova JL, Blanche S, Emile JF, Jouanguy E, Lamhamedi S, Altare F, et al. Idiopathic disseminated bacillus Calmette-Guerin infection: a French national retrospective study. Pediatrics. 1996; 98(4 Pt 1): 774-8[PubMed]
  • 7. Afshar Paiman S, Siadati A, Mamishi S, Tabatabaie P, Khotaee G. Disseminated Mycobacterium bovis infection after BCG vaccination. Iran J Allergy Asthma Immunol. 2006; 5(3): 133-7[PubMed]
  • 8. Deeks SL, Clark M, Scheifele DW, Law BJ, Dawar M, Ahmadipour N, et al. Serious adverse events associated with bacille Calmette-Guerin vaccine in Canada. Pediatr Infect Dis J. 2005; 24(6): 538-41[PubMed]
  • 9. Sadeghi-Shabestari M, Rezaei N. Disseminated bacille Calmette-Guerin in Iranian children with severe combined immunodeficiency. Int J Infect Dis. 2009; 13(6): 420-3[DOI][PubMed]
  • 10. Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol. 2006; 26(6): 519-32[DOI][PubMed]
  • 11. Hesseling AC, Rabie H, Marais BJ, Manders M, Lips M, Schaaf HS, et al. Bacille Calmette-Guerin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis. 2006; 42(4): 548-58[DOI][PubMed]
  • 12. Rabie H, Violari A, Duong T, Madhi SA, Josipovic D, Innes S, et al. Early antiretroviral treatment reduces risk of bacille Calmette-Guerin immune reconstitution adenitis. Int J Tuberc Lung Dis. 2011; 15(9): 1194-200[DOI][PubMed]
  • 13. Barnard M, Gey van Pittius NC, van Helden PD, Bosman M, Coetzee G, Warren RM. The diagnostic performance of the GenoType MTBDRplus version 2 line probe assay is equivalent to that of the Xpert MTB/RIF assay. J Clin Microbiol. 2012; 50(11): 3712-6[DOI][PubMed]
  • 14. Hillemann D, Rusch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol. 2007; 45(8): 2635-40[DOI][PubMed]
  • 15. Yadav RN, Singh BK, Sharma SK, Sharma R, Soneja M, Sreenivas V, et al. Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India. PLoS One. 2013; 8(9): 72036[DOI][PubMed]
  • 16. Ying W, Sun J, Liu D, Hui X, Yu Y, Wang J, et al. Clinical characteristics and immunogenetics of BCGosis/BCGitis in Chinese children: a 6 year follow-up study. PLoS One. 2014; 9(4): 94485[DOI][PubMed]
  • 17. Aelami MH, Alborzi A, Pouladfar G, Geramizadeh B, Pourabbas B, Mardaneh J. Post-Vaccination Disseminated Bacillus Calmette Guerin Infection Among Children in Southern Iran. Jundishapur J Microbiol. 2015; 8(11): 25663[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments